# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-14-007389
Filing Date
2014-10-21
Accepted
2014-10-21 08:31:40
Documents
45
Period of Report
2014-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k102114_actiniumpharma.htm | 8-K | 24985
2 | KOL EVENT LEAD PROGRAMS OVERVIEW PRESENTATION. | f8k102114ex99i_actinium.htm | EX-99.1 | 9424
3 | KOL PRESENTATION, DATED OCTOBER 21, 2014. | f8k102114ex99ii_actinium.htm | EX-99.2 | 29120
4 | GRAPHIC | slide1.jpg | GRAPHIC | 117397
5 | GRAPHIC | slide2.jpg | GRAPHIC | 111702
6 | GRAPHIC | slide3.jpg | GRAPHIC | 120702
7 | GRAPHIC | slide4.jpg | GRAPHIC | 114946
8 | GRAPHIC | slide5.jpg | GRAPHIC | 104694
9 | GRAPHIC | slide6.jpg | GRAPHIC | 176070
10 | GRAPHIC | slide7.jpg | GRAPHIC | 87909
11 | GRAPHIC | slide8.jpg | GRAPHIC | 135458
12 | GRAPHIC | slide9.jpg | GRAPHIC | 91667
13 | GRAPHIC | slide10.jpg | GRAPHIC | 91638
14 | GRAPHIC | slide11.jpg | GRAPHIC | 157765
15 | GRAPHIC | slide12.jpg | GRAPHIC | 170338
16 | GRAPHIC | slide13.jpg | GRAPHIC | 219605
17 | GRAPHIC | slide14.jpg | GRAPHIC | 182721
18 | GRAPHIC | slide15.jpg | GRAPHIC | 206909
19 | GRAPHIC | slide16.jpg | GRAPHIC | 122133
20 | GRAPHIC | slide17.jpg | GRAPHIC | 209629
21 | GRAPHIC | slide18.jpg | GRAPHIC | 156948
22 | GRAPHIC | slide19.jpg | GRAPHIC | 164237
23 | GRAPHIC | slide20.jpg | GRAPHIC | 91379
24 | GRAPHIC | slide21.jpg | GRAPHIC | 163490
25 | GRAPHIC | slide22.jpg | GRAPHIC | 112712
26 | GRAPHIC | slide23.jpg | GRAPHIC | 126527
27 | GRAPHIC | slide24.jpg | GRAPHIC | 99229
28 | GRAPHIC | slide25.jpg | GRAPHIC | 121213
29 | GRAPHIC | slide26.jpg | GRAPHIC | 155307
30 | GRAPHIC | slide27.jpg | GRAPHIC | 88628
31 | GRAPHIC | slide28.jpg | GRAPHIC | 95587
32 | GRAPHIC | slide29.jpg | GRAPHIC | 175883
33 | GRAPHIC | slide30.jpg | GRAPHIC | 154039
34 | GRAPHIC | slide31.jpg | GRAPHIC | 190286
35 | GRAPHIC | img1.jpg | GRAPHIC | 37873
36 | GRAPHIC | img2.jpg | GRAPHIC | 110173
37 | GRAPHIC | img3.jpg | GRAPHIC | 31858
38 | GRAPHIC | img4.jpg | GRAPHIC | 53167
39 | GRAPHIC | img5.jpg | GRAPHIC | 51384
40 | GRAPHIC | img6.jpg | GRAPHIC | 47673
41 | GRAPHIC | img7.jpg | GRAPHIC | 40071
42 | GRAPHIC | img8.jpg | GRAPHIC | 51305
43 | GRAPHIC | img9.jpg | GRAPHIC | 63168
44 | GRAPHIC | img10.jpg | GRAPHIC | 40048
45 | GRAPHIC | img11.jpg | GRAPHIC | 37873
| Complete submission text file | 0001213900-14-007389.txt |  | 6795847

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141164944
SIC: 2834 Pharmaceutical Preparations